Oxitropium bromide
![]() | |
| Clinical data | |
|---|---|
| Trade names | Oxivent, Tersigan, Tersigat, Ventilat |
| AHFS/Drugs.com | International Drug Names |
| ATC code | R03BB02 (WHO) |
| Identifiers | |
| |
| Synonyms | N-Ethylscopolammonium bromide; Ba 253; Ba 253BR-L; Ba 253Br; Hyoscine ethobromide; N-Ethylnorscopolamine methyl bromide; Scopolamine ethobromide |
| CAS Number | 30286-75-0 |
| ChemSpider | 16735948 |
| UNII | SF4NW7NH7C |
| ChEMBL | CHEMBL1697846 |
| ECHA InfoCard | 100.045.543 |
| Chemical and physical data | |
| Formula | C19H26BrNO4 |
| Molar mass | 412.32 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Oxitropium bromide (trade names Oxivent, Tersigan) is a bronchodilator indicated for asthma and chronic obstructive pulmonary disease.[1]
References
This article is issued from Wikipedia - version of the 8/28/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
